6.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (general) only if he or she is and to the extent certified under this regulation as having a cleared status (general).
[S 590/2021 wef 10/08/2021]
[S 908/2021 wef 01/12/2021]
(2) Where the Director or a recognised medical practitioner is satisfied that an individual is a recovered individual, the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (general) for a period —
(a)
for a recovered individual who was never vaccinated against a COVID-19 infection before he or she was diagnosed as having the COVID‑19 infection —
(i)
starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing any of the following that led to the diagnosis of the individual having that infection:
(A)
a polymerase chain reaction test;
(B)
an antigen rapid test which had been followed by a serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection;
(C)
an antigen rapid test on or after 6 January 2022 that is performed by or under the direction of the individual’s treating doctor in the course of providing medical treatment to the individual because the individual has acute respiratory symptoms; and
[S 9/2022 wef 06/01/2022]
(ii)
ending on (and including) as follows:
(A)
the 180th day after the date in sub-paragraph (i), unless sub-paragraph (B) applies;
(B)
31 January 2022, where the individual is a transitional case; or
[S 991/2021 wef 01/01/2022]
[S 590/2021 wef 10/08/2021]
(b)
for a recovered individual who is diagnosed as having a COVID‑19 infection after a certificate under this paragraph had been granted in respect of the individual, and who was never vaccinated against a COVID‑19 infection, the period falling after the grant of the certificate —
(i)
starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing any of the following that led to the diagnosis of the individual having that infection:
(A)
a polymerase chain reaction test;
(B)
an antigen rapid test followed by a serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection;
(C)
an antigen rapid test on or after 6 January 2022 that is performed by or under the direction of the individual’s treating doctor in the course of providing medical treatment to the individual because the individual has acute respiratory symptoms; and
[S 9/2022 wef 06/01/2022]
(ii)
ending on (and including) as follows:
(A)
the 180th day after the date in sub-paragraph (i), unless sub-paragraph (B) applies;
(B)
31 January 2022, where the individual is a transitional case.
[S 991/2021 wef 01/01/2022]
[S 590/2021 wef 10/08/2021]
(3) Where the Director is satisfied that —
(a)
an individual is a recovered individual;
(b)
the individual is vaccinated against a COVID-19 infection by the administration of any approved vaccine by a recognised vaccination provider; and
(c)
14 days or more have elapsed after the day the individual was so vaccinated,
the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule.
(4) In addition, where the Director is satisfied that —
(a)
the individual (who is not a recovered individual) is vaccinated against a COVID‑19 infection by the administration of any approved vaccine by a recognised vaccination provider; and
(b)
14 days or more have elapsed after the day the individual was so vaccinated,
the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule.
(5) Despite paragraph (2), (3) or (4) and except where expressly provided in paragraph (5A), where an individual is diagnosed as having a COVID-19 infection, after he or she is —
(a)
vaccinated against the COVID-19 infection; and
(b)
granted a certificate under paragraph (3) or (4),
then the Director or a recognised medical practitioner may, where satisfied that the individual is a recovered individual after that infection or any later infection, grant a certificate stating that the individual has a cleared status (general) for the period —
(c)
starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing any of the following that led to the diagnosis of the individual having the last infection he or she recovered from:
(i)
a polymerase chain reaction test;
(ii)
an antigen rapid test followed by a serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection;
(iii)
an antigen rapid test on or after 6 January 2022 that is performed by or under the direction of the individual’s treating doctor in the course of providing medical treatment to the individual because the individual has acute respiratory symptoms; and
[S 9/2022 wef 06/01/2022]
(d)
ending on (and including) —
(i)
the 180th day after the date in sub-paragraph (c); or
[S 991/2021 wef 01/01/2022]
(ii)
the day the period referred to in and applicable to the individual under paragraph (3) or (4) would have ended if the individual had not been diagnosed as having a COVID-19 infection,
whichever day is later.
[S 590/2021 wef 10/08/2021]
[S 991/2021 wef 01/01/2022]
(5A) Where the Director is satisfied that an individual (of any age) —
(a)
has received one dose of any defined approved vaccine and one dose of any other approved vaccine, each administered to the individual at least 17 days apart regardless of sequence;
[S 9/2022 wef 06/01/2022]
(b)
subsequently tests positive for SARS-CoV-2 upon undergoing any of the following:
(i)
a polymerase chain reaction test in Singapore;
(ii)
a polymerase chain reaction test outside Singapore, and a subsequent serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection;
(iii)
an antigen rapid test followed by a serology test in Singapore that is not attributable to the administration of any vaccine against a COVID-19 infection;
[S 9/2022 wef 06/01/2022]
(iv)
an antigen rapid test (on or after 6 January 2022) in Singapore that is performed by or under the direction of the individual’s treating doctor in the course of providing medical treatment to the individual because the individual has acute respiratory symptoms;
[S 9/2022 wef 06/01/2022]
[S 9/2022 wef 06/01/2022]
(c)
is diagnosed as having had a COVID-19 infection;
[S 9/2022 wef 06/01/2022]
(d)
is no longer actively infected with a COVID-19 infection; and
(e)
is without a cleared status (general), cleared status (special) or a cleared status (overseas temporary),
the Director may grant a certificate stating that the individual has a cleared status (general) for a period —
(f)
starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test mentioned in sub-paragraph (b) leading to the diagnosis of the individual having the last infection he or she recovered from; and
(g)
ending on (and including) the 365th day after the date in sub-paragraph (f).
[S 991/2021 wef 01/01/2022]
(6) The Director may cancel any certificate granted under this regulation stating that an individual has a cleared status (general) if —
(a)
[Deleted by S 9/2022 wef 06/01/2022]
(b)
the Director is satisfied that it is the interest of the health and safety of the individual to do so.
[S 590/2021 wef 10/08/2021]
(7) To avoid doubt, the period in paragraph (3), (4) or (5) may be a period before 24 April 2021.
[S 590/2021 wef 10/08/2021]
(8) An individual is a transitional case for the purposes of paragraph (2) —
(a)
if he or she had acquired, before 1 January 2022, a cleared status (general) under paragraph (2), and would have continued on or after that date to have a cleared status (general) if not for the making of the Infectious Diseases (Mass Gathering Testing for Coronavirus Disease 2019) (Amendment No. 14) Regulations 2021; but
(b)
not if he or she had acquired, before 1 January 2022, a cleared status (general) under paragraph (2) and ceased to have a cleared status (general) that is current before that date because of regulation 8A(1)(a) or (c).